Overview

A Study to Assess the Safety and Pharmacokinetics of Oral Sodium Oligo-mannurarate (GV-971) in Healthy Chinese Subjects

Status:
Unknown status

Trial end date:
2018-12-31

Target enrollment:

Participant gender:

Summary

To evaluate the safety and pharmacokinetics of GV-971 capsules after oral a single or multiple doses of 900 mg, 1200 mg and 1500 mg in healthy subjects.

Phase:

Phase 1

Details

Lead Sponsor:

Shanghai Greenvalley Pharmaceutical Co., Ltd.